Coexistence of type 1 and type 2 diabetes mellitus: "Double" diabetes?

Pediatric Diabetes

Volumn 4, Issue 2, 2003, Pages 110-113

  Libman, Ingrid M ^a   Becker, Dorothy J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

"double" diabetes; Adolescents; Children

Indexed keywords

ENALAPRIL MALEATE; ISOPHANE INSULIN; METFORMIN;

ARTICLE; CASE REPORT; COMORBIDITY; DIABETES CONTROL; DIABETIC RETINOPATHY; FAMILY HISTORY; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SIBLING;

BLOOD GLUCOSE; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; TIME FACTORS;

EID: 0037711693     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5448.2003.00012.x     Document Type: Article

References (25)

1. Gordon BL. Medieval and Renaissance Medicine. Philosophical Library Inc, New York, 1960.
2. MacCracken J, Hoel D. From ants to analogues. Puzzles and promises in diabetes management. Postgrad Med 1997: 101(4): 138-141.
3. http://www-unix.oit.umass.edu/~abhuooo/diabetes/edson.html
4. National Diabetes Data Group. Diabetes in America, 2nd edn. Publication no. 95-1468. National Institutes of Health, Bethesda, 1995.
5. Pinhas-Hamiel O, Dolan LM, Daniels SR et al. Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr 1996: 128: 608-615.
6. Scott C, Smith J, Cradock M, Pihoker C. Characteristics of youth-onset non-insulin dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics, 1997: 100: 84-91.
7. Neufeld N, Raffel L, Landon C, Chen Y, Valdheim C. Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care, 1998: 21: 80-86.
8. Dabelea D, Hanson R, Bennett P et al. Increasing prevalence of type 2 diabetes in American Indian children. Diabetologia, 1998: 41: 904-910.
9. Pinhas-Hamiel O, Zeitler P. The importance of a name. N Engl J Med 1999: 340: 1418-1421.
10. Fagot-Campagna A, Imperatore G, Narayan V, Engelgau M. Diabetes mellitus: type 1 or type 2? (Letters). J Pediatr 2001: 138: 612-613.
11. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000: 23: 381-389.
12. Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997: 20: 484-486.
13. Orchard TJ. From diagnosis and classification to complications and therapy. DCCT II? Diabetes Control Complications Trial. Diabetes Care 1994: 17: 326-338.
14. Libman I, Pietroapolo M, Arslanian S, Laporte R, Becker D. Changing phenotype: are more youngsters with IDDM obese at onset? Diabetologia, 2001: 44(Suppl. 1): A257.
15. Yki-Jarvinen H. Acute and chronic effects of hyperglycaemia on glucose metabolism. implications for the development of new therapies. Diabet Med 1997: 14(Suppl. 3): S32-S37.
16. Erbey J, Kuller L, Becker D, Orchard T. The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 1998: 21: 610-614.
17. Williams K, Erbey J, Becker D, Arslanian S, Orchard T. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000: 49: 626-632.
18. Libman IM, Pietropaolo M, Arslanian S, Laporte RE, Becker DJ. Do Black children have type 1 plus type 2 diabetes? Diabetologia 2000: 43(Suppl. 1): A27.
19. Hathout EH, Thomas W, El-Shahawy M, Nahab F, Mace J. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics, 2001: 107: E102.
20. Rapaport R, Wallach E, Greig F, Iazzetti L. Diabetes mellitus: type 1 or type 2? J Pediatr, 2001: 138: 612.
21. Pihoker C, Brooks-Worrell B, Greenbaum C, Palmer J. Impact of islet reactive T cells and autoantibodies in clinical diagnosis of type 1, type 2 or atypical diabetes in children. Diabetes 2000: 49 (Suppl. 1): A409.
22. Janeja R, Palmer JP: Type 1 1/2 diabetes: myth or reality? Autoimmunity 1999: 29(1): 65-83.
23. Tuomi T, Groop LC, Zimmet PZ et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin dependent onset of disease. Diabetes 1993: 42: 359-362.
24. Hamilton J, Cummings E, Zdravkovic D. Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 2003: 26: 138-143.
25. Nathan D. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002: 347: 1342-1349.